The Evolution of RPM: Societal Drivers, Technology, Economics, and Opportunities
The Evolution of RPM: Societal Drivers, Technology, Economics, and Opportunities Chet Thaker CEO, TeleBright Software Corporation Chet Thaker, an entrepreneur with a focus on utilizing technology to solve complex problems, reflects on the rapidly changing
Heart Team Approach
Heart Team Approach Mun Hong, MD, MHCM, FACC Mun Hong, MD, MHCM, FACC, a highly esteemed interventional cardiologist, addresses one of the most pressing challenges in modern medicine—advanced cardiovascular conditions such as severe coronary artery
Debbie’s Dream Foundation: Pioneering Advocacy and Research in the Fight Against Stomach Cancer
Debbie’s Dream Foundation: Pioneering Advocacy and Research in the Fight Against Stomach Cancer Interview with Andrea Eidelman CEO, Debbie's Dream Foundation(DDF) Stomach cancer, though less common in the U.S. compared to other cancers, remains one
Sustaining the Healthcare Workforce: Combating Physician and Nurse Shortages in America
Sustaining the Healthcare Workforce: Combating Physician and Nurse Shortages in America Larry I. Slatky, Healthcare Consultatn (Advisor, W Medical Strategy Group) The United States faces an escalating crisis in healthcare: a severe shortage of physicians,
The Global OR – An Introduction to Global Surgery
The Global OR – An Introduction to Global Surgery Kee B. Park, MD, MPH, Dawn Poh, MBBS, MRes Introduction An estimated 5 billion people worldwide lack access to timely, affordable, and safe surgical care, including
Overcoming Disparities in Gastric Cancer Care
Overcoming Disparities in Gastric Cancer Care Chul S. Hyun, MD, PhD, MPH Gastric Cancer and Prevention Screening Program, Yale School of Medicine, New Haven, CT Gastric cancer is the fifth most common cancer worldwide,
South Korea’s Healthcare Crisis: Beyond the Numbers
South Korea’s Healthcare Crisis: Beyond the Numbers Dongju Shin, Dong-Jin Shin INTRODUCTION The South Korean healthcare system has recently plunged into a significant crisis following a February 2024 announcement by the government to increase medical
The Strategic Importance of Location in the U.S. for Foreign Bio and Pharma Companies
The Strategic Importance of Location in the U.S. for Foreign Bio and Pharma Companies DoHyun Cho, PhD (CEO, W Medical Strategy Group) The U.S. Market: A Cornerstone of Global Expansion For pharmaceutical and biotech companies,
